TY - JOUR T1 - Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00512-2022 VL - 8 IS - 4 SP - 00512-2022 AU - Graham H. Bothamley Y1 - 2022/10/01 UR - http://openres.ersjournals.com/content/8/4/00512-2022.abstract N2 - In this issue of ERJ Open Research, Korhonen et al. [1] describe their experience of multidrug-resistant tuberculosis (MDR-TB) in Finland from 2007 to 2016. 47 clinical cases were included and act as historical background to the major changes in treatment regimens proposed by the World Health Organization (WHO) [2].The account of MDR-TB in Finland describes current practice. Genetic testing of primary specimens, whole-genome sequencing, supportive directly observed therapy, checklists and national consilia will contribute to further improvements in managing MDR-TB. https://bit.ly/3rOnb3u ER -